Education
About Us
Working with TipRanks
Follow Us
Inscobee Inc. Insider Profile
4 Followers
Inscobee Inc., Ten Percent Owner at Apimeds Pharmaceuticals US, Inc., holds 6.42M shares in Apimeds Pharmaceuticals US, Inc. (Ticker: APUS). Most recently, Inscobee Inc. Bought 297,153 shares of Apimeds Pharmaceuticals US, Inc. on May 14, 2025 for an estimated value of $772.60K.
Inscobee Inc. Apimeds Pharmaceuticals US, Inc. (APUS)Ten Percent Owner
Apimeds Pharmaceuticals US, Inc. (APUS)
Ten Percent Owner
Ranked #53,127 out of 104,058 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-1.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that Inscobee Inc. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 14, 2025 - Today
Return:-1.00%
The most profitable trade made by Inscobee Inc.
Inscobee Inc.'s Trading History
List of latest transactions for each holding click on a transaction to see Inscobee Inc.'s performance on stock
You May Also Like
Inscobee Inc. insider profile FAQ
What is the percentage of profitable transactions made by Inscobee Inc.?
The percentage of profitable transactions made by Inscobee Inc. is 0%.
What is the average return per transaction made by Inscobee Inc.?
The average return per transaction made by Inscobee Inc. is -1.00%.
What stocks does Inscobee Inc. hold?
Inscobee Inc. holds: APUS stocks.
What was Inscobee Inc.’s latest transaction?
Inscobee Inc. latest transaction was an Informative Buy of $772.60K.
What was Inscobee Inc.'s most profitable transaction?
Inscobee Inc.’s most profitable transaction was an Informative Buy of APUS stock on May 14, 2025. The return on the trade was -1.00%.
What is Inscobee Inc.'s role in Apimeds Pharmaceuticals US, Inc.?
Inscobee Inc.'s role in Apimeds Pharmaceuticals US, Inc. is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.